Enpicom B.V.

We make up a top-class and diverse team of experts, with the right combination of knowledge and expertise to jointly tackle the data analysis and software engineering challenges related to the field of immunomics. Together with our scientific and strategic partners and supported by our investors, we aim to develop tools and validate applications to truly bridge the gap between immune repertoire sequencing and the insights needed to improve the health of patients treated with immunotherapy or affected by immune system related diseases or conditions. ENPICOM aims to become the global leader in personalizing immunotherapy with groundbreaking bioinformatics methods and state-of-the-art software to accelerate drug development, and improve patient stratification & treatment monitoring of immunotherapies.